foxo4 dri clinical trial human FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Dose:2.00–2.40 mg Shipping FDA Meeting Approves Peptides:
SKU: 37800705665
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9

























